Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Guideline-directed Medical Therapy is the Most Effective Decongestion
Author(s): Jelena Celutkiene , Alexandre Mebazaa , Jan Biegus , et al Added: 1 year ago

Heart Failure
FDA Approves Finerenone for Heart Failure with LVEF ≥40%
Added: 7 months ago Source:  Radcliffe Cardiology
The US Food and Drug Administration (FDA) has approved the non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) finerenone (Kerendia, Bayer). The new indication is for adult patients with heart failure (HF) and a left ventricular ejection fraction (LVEF) of ≥40% to reduce the risk of cardiovascular death, hospitalisation for heart failure, and urgent heart failure visits.¹ The… View more

Cardiovascular Renal Metabolic

Guidelines & Statements
The Art and Science of Congestion Diagnosis and Management in Heart Failure
Author(s): Josip A Borovac , Dino Miric Added: 3 months ago

Heart Failure
Pharmacological Therapy of HFrEF in 2025
Author(s): Massimo Mapelli , Filippo Maria Rubbo , Simona Costantino , et al Added: 8 months ago

Heart Failure
Jozine ter Maaten
Research Area(s) / Expertise:

Heart Failure

 Job title: Cardiologist
Dr Jozine ter Maaten is a cardiologist at the University Medical Center Groningen, specializing in acute heart failure. Her research focuses on understanding congestion and improving diuretic response and outcomes in patients with this condition. Dr ter Maaten completed her PhD on 'Diuretic response and renal biomarkers in heart failure' in 2016 and has since been actively involved in research… View more
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 11 months ago

Prevention & Chronic Conditions

Heart Failure
Simple Risk Stratification Could Optimise Heart Failure Follow-Up and Outcomes
Added: 7 months ago Source:  Radcliffe Cardiology
A new nationwide cohort study from France suggests that a simple risk stratification tool based on administrative data could help tailor cardiologist follow-up for patients with heart failure (HF), potentially improving survival and optimising resource use. The study found that 40% of patients with HF do not have an annual cardiology consultation, regardless of their disease severity.¹The French… View more

Digital Health

Guidelines & Statements
THT 2025: The FASTR Trial
Author(s): James Udelson Added: 1 year ago
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the… View more

Heart Failure
‘Residual Congestion’ in HF
Author(s): Aleksandra Gasecka , Aleksander Siniarski Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Advances in Congestion Assessment in Decompensated Heart Failure
Author(s): Archana Ganapathy , Jason N Dungu , Anthony D Dimarco , et al Added: 1 month ago

Heart Failure